Interview with Juan Craveri, President and CEO, Craveri
Craveri has one of the most distinguished histories of any of the Argentine pharmaceutical companies, with over 120 years of history. Three generations after it’s foundation, do you feel you…
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. At present, Aegerion is in the process of registering lomitapide in markets worldwide, and plans to conduct clinical development activities to support a marketing authorization application for lomitapide in HoFH in Japan and in support of our planned clinical study of lomitapide in pediatric and adolescent HoFH patients.
Contact info:
Rosario Cestau
Country Manager, Argentina
Av. Libertador 2442, Suite 406 {B1636DSR} Olivos, Buenos Aires
Tel: +5411 – 4711 8228 | Mobile: +54 911 3874 7608
rcestau@aegerion.com | www.aegerion.com
Craveri has one of the most distinguished histories of any of the Argentine pharmaceutical companies, with over 120 years of history. Three generations after it’s foundation, do you feel you…
Could you briefly explain your history in the Argentinean pharmaceutical industry? I began my career in the pharmaceutical industry as the Marketing Director at MSD, where I worked for 17…
The Bayer Schering merger in 2006 saw you add Argentina and Bolivia to your existing responsibilities as General Manager of Schering for Paraguay and Uruguay. What have been some of…
It’s safe to assume that everywhere that IMS Health is established, there’s also a flourishing pharmaceutical industry. Could you give us an overview of Argentina’s IMS operations? IMS has been…
¿Cual fue la visión de la creación de ANMAT y las circunstancias de su creación? En el momento de la creación del ANMAT, el Gobierno Nacional entendió las necesidades de…
Sidus was originally established in 1938. Today, the Sidus Pharmaceutical Group is one of the most respected in Argentina and Latin America. To what extent is the company today still…
Your entry into the Argentinean pharmaceutical market in 2004 was very unconventional, with your ‘holistic solution’ that had not been seen before in Argentina. Why was the time right in…
Boasting three Nobel Prize winners from the life sciences, Argentina has had a long history of innovation. Immigration from Europe at the end of the 19th century saw the…
¿Cual fue la visión detrás de la creación de IBC y Dromex? Nuestro negocio original consistía en representar comercialmente a los fabricantes de APIs europeos. Esto me llevo a tender…
¿Cuál es la historia de Laboratorios Poen y como ha crecido en los últimos años? Poen se inició siendo un pequeño laboratorio de capitales nacionales dedicado fundamentalmente a la oftalmología.…
You were General Manager of Pfizer Peru and Pfizer Venezuela before taking on the challenge of the Argentinean market. How difficult was the experience of adjusting to this unique environment?…
¿Porque fue creado en Ministerio de Ciencia y Tecnología, con que visión? Muchos países están aportando importancia a la ciencia y tecnología y representa la razón del desarrollo económico y…
See our Cookie Privacy Policy Here
